reconsider

U.S. doctors reconsider Pfizer’s Paxlovid for lower-risk COVID patients

By Deena Beasley (Reuters) – Use of Pfizer Inc’s COVID-19 antiviral Paxlovid spiked this week, however some docs are reconsidering…